longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Thermo Fisher Scentific

TMO

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 34.04, within the reasonable range, cheaper than 35.04% of the time in the past 3 years, and the industry ranks 8/59, the industry Median -1.55.

34.04xP/E
$641.39Stock price
$18.84Earnings per share
34.04xP/E
Stock price$641.39Earnings per share$18.84

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
32.48x
Typical range
27.23x–35.82x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
TMOUSThermo Fisher Scentific
34.04x13.43%$237.15B
DHRUSDanaher
36.76x17.40%$147.18B
IQVUSIQVIA
32.28x0.96%$44.39B
AUSAgilent Tech
29.42x12.34%$42.37B
MTDUSMettler Toledo
29.43x10.40%$26.66B
WXXWYUSWuXi Biologics
35.73x--$25.73B
MEDPUSMedpace
35.24x15.09%$17.32B
QGENUSQiagen NV
21.43x0.70%$8.77B
STVNUSStevanato Group SpA
37.65x8.92%$5.88B
SHCUSSotera Health
33.13x154.32%$5.42B
BLFSUSBioLife Solutions
30.69x1,266.67%$1.78B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.